Cumberland Pharmaceuticals Inc. Active Patents
9 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2020-05-07: Application 16869277; Invention INJECTABLE IBUPROFEN FORMULATION; Applicant Cumberland Pharmaceuticals Inc.; Status Patented Case.
- 2019-11-18: Application 16687151; Invention Thromboxane Receptor Antagonists in AERD/; Applicant Cumberland Pharmaceuticals Inc.; Status Patented Case.
- 2018-04-04: Application 15945126; Invention DOSES AND METHODS FOR ADMINISTERING TELAVANCIN; Applicant Cumberland Pharmaceuticals Inc.; Status Patented Case.
- 2017-04-11: Application 15484349; Invention TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN; Applicant Cumberland Pharmaceuticals Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-05-07 | 16869277 | INJECTABLE IBUPROFEN FORMULATION | Cumberland Pharmaceuticals Inc. | Patented Case | 2023-11-07 | 11806400 | US20200261581A1 | Leo PAVLIV Andrew VILA | United States United States | MCMILLIAN, KARA RENITA |
| 2019-11-18 | 16687151 | Thromboxane Receptor Antagonists in AERD/ | Cumberland Pharmaceuticals Inc. | Patented Case | 2023-02-07 | 11571412 | US20200155513A1 | Leo PAVLIV | United States | THOMAS, TIMOTHY P |
| 2018-04-04 | 15945126 | DOSES AND METHODS FOR ADMINISTERING TELAVANCIN | Cumberland Pharmaceuticals Inc. | Patented Case | 2020-08-25 | 10751383 | US20180236027A1 | Steven L. Barriere Arthur Lo Mathai Mammen Philip Worboys | United States United States United States United States | GARYU, LIANKO G |
| 2017-04-11 | 15484349 | TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN | Cumberland Pharmaceuticals Inc. | Patented Case | 2018-04-03 | 9931311 | US20170216232A1 | Leo Pavliv Amy Dix Rock | United States United States | CORNET, JEAN P |
| 2015-08-13 | 14825803 | TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN | Cumberland Pharmaceuticals Inc. | Patented Case | 2017-05-16 | 9649284 | US20160113894A1 | Leo PAVLIV Amy Dix Rock | United States United States | CORNET, JEAN P |
| 2014-10-06 | 14507331 | TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN | Cumberland Pharmaceuticals Inc. | Patented Case | 2015-09-22 | 9138404 | US20150087710A1 | Leo Pavliv Amy Dix Rock | United States United States | CORNET, JEAN P |
| 2014-04-29 | 14264267 | TREATING PATIENTS WITH INTRAVENOUS IBUPROFEN | Cumberland Pharmaceuticals Inc. | Patented Case | 2015-08-25 | 9114068 | US20140235720A1 | Leo Pavliv Amy Dix Rock | United States United States | CORNET, JEAN P |
| 2014-03-25 | 14225345 | Acetylcysteine Compositions and Methods of use Thereof | Cumberland Pharmaceuticals, Inc. | Patented Case | 2016-05-03 | 9327028 | US20140206765A1 | Leo Pavliv Amy Rock | United States United States | BAEK, BONG-SOOK |
| 2013-01-22 | 13746999 | STABILIZED STATIN FORMULATIONS | CUMBERLAND PHARMACEUTICALS INC. | Patented Case | 2015-01-13 | 8933115 | US20130137745A1 | Leo PAVLIV Andrew VILA | United States United States | IVANOVA, SVETLANA M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |